{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Dibrospidium_Chloride",
  "nciThesaurus": {
    "casRegistry": "86641-76-1",
    "chebiId": "",
    "chemicalFormula": "C18H32Br2N4O2.2Cl",
    "definition": "A dispirotripiperazine derivative and alkylating agent with potential antineoplastic and anti-inflammatory activities. Dibrospidium chloride has been examined for the treatment of bone cancer.",
    "fdaUniiCode": "GRX5L9Y3Z3",
    "identifier": "C81362",
    "preferredName": "Dibrospidium Chloride",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C1590"
    ],
    "synonyms": [
      "DIBROSPIDIUM CHLORIDE",
      "Dibrospidium Chloride"
    ]
  }
}